Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The main intercellular adhesion proteins in the stratum corneum are structural elements that maintain the cohesion and integrity of the skin barrier. Key proteins include Desmoglein 1 (DSG1) and Desmocollin 1 (DSC1), both members of the cadherin superfamily, which form the core molecules of corneodesmosomes—specialized adhesive junctions that bind corneocytes together[1][2][4]. Corneodesmosin (CDSN) is another crucial component, secreted by upper epidermal keratinocytes, that reinforces the adhesive structure. The orderly degradation of these complexes by proteases governs the normal shedding (desquamation) of corneocytes and the maintenance of skin barrier homeostasis. Abnormalities in these proteins or their regulated proteolysis can underlie human skin diseases linked to barrier dysfunction and inflammation[1][2][4].
Not applicable (no approved drugs directly targeting these proteins)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stratum corneum intercellular adhesion proteins.